Peter Michelson, M.D.

Profile picture
Professor of Pediatrics, Allergy, Immunology and Pulmonary Medicine
Director, Washington University School of Medicine CF Center
Allergy, Immunology and Pulmonary Medicine

phone: (314) 454-2694

Clinical Interests

Dr. Michelson is a member of the Division of Allergy, Immunology and Pulmonary Medicine. Although recently relocated to St Louis, he has been a practicing pediatric pulmonologist since 1995. Dr. Michelson attended medical school at Jefferson Medical College in Philadelphia, PA and completed his residency at St Christopher’s Hospital for Children, also in Philadelphia. After 5 years working for the Indian Health Service in Anchorage, AK, he completed his training in Pulmonary Medicine at University of North Carolina. He is board certified in Pediatrics and Pediatric Pulmonary Medicine. Dr. Michelson is the Director of the Cystic Fibrosis Center at St Louis Children’s Hospital and is both a member of the American Thoracic Society and the International Society for Heart and Lung Transplantation. Dr. Michelson’s research focus will continue to be outcomes research addressing new therapies for patients with cystic fibrosis (CF) as well as pediatric patients undergoing lung transplantation. Additionally, he will continue to advance SLCH’s quality improvement projects relating to pediatric asthma and pulmonary medicine, specifically examining means to advance CF clinical care.


  • AB, cum laude, honors in Biochemistry, Bowdoin College1978
  • MD, Jefferson Medical College1983
  • MSc, University of Pittsburgh School of Medicine2006
  • AA, Northwestern University2013


  • Resident, Temple University School of Medicine, St. Christopher's Hospital for Children1983 - 1986
  • Fellow, University of North Carolina School of Medicine1992 - 1995

Licensure and Board Certification

  • 1987 - PresAmerican Board of Pediatrics
  • 1996 - PresAmerican Board of Pediatrics, Sub Board in Pediatric Pulmonology (recertified 2004, 2011, 2015)

Honors and Awards

  • Achievement Medal, US Public Health Service1990
  • Unit Commendation, US Public Health Service1991
  • CF Research Care Partner, Carolinas Chapter2008
  • Quality Care Award, St. Louis Children's CF Center, St. Louis, MO2013 - 2014
  • Outstanding CFF Care Center Partner, St. Louis Children's Hospital2014

Recent Publications view all (17)

Publication Co-Authors

  1. Ready-to-Use Supplemental Food for Nutritional Supplementation in Cystic Fibrosis. Curr Dev Nutr. 2019;3(5):nzz016. doi:10.1093/cdn/nzz016  PMCID:PMC6468303  PMID:31011716 
  2. Reduction in Mortality Following Pediatric Rapid Response Team Implementation. Pediatr Crit Care Med. 2018;19(5):477-482. PMID:29528975 
  3. Official American Thoracic Society technical standards: flexible airway endoscopy in children. Am J Respir Crit Care Med. 2015;191(9):1066-80. doi:10.1164/rccm.201503-0474ST  PMID:25932763 
  4. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. J Cyst Fibros. 2015;14(2):219-27. doi:10.1016/j.jcf.2014.08.008  PMID:25228446 
  5. Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis. J Heart Lung Transplant. 2013;32(6):621-5. doi:10.1016/j.healun.2013.03.002  PMID:23701851 
  6. Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas. Pediatr Pulmonol. 2010;45(3):281-90. doi:10.1002/ppul.21176  PMID:20146365 
  7. Obesity, inflammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004. Ann Allergy Asthma Immunol. 2009;103(5):381-5. doi:10.1016/S1081-1206(10)60356-0  PMID:19927535 
  8. Refractory hypercalcemia in an infant secondary to talc pleurodesis resolving after renal transplantation. Am J Transplant. 2008;8(6):1329-33. doi:10.1111/j.1600-6143.2008.02216.x  PMID:18444935 
  9. Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J Heart Lung Transplant. 2008;27(6):655-61. doi:10.1016/j.healun.2008.03.010  PMCID:PMC2447528  PMID:18503966 
  10. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Pediatr Transplant. 2008;12(4):464-8. doi:10.1111/j.1399-3046.2007.00835.x  PMID:18466434 
  11. Intensive care management of the patient with cystic fibrosis. J Intensive Care Med. 2008;23(3):159-77. doi:10.1177/0885066608315679  PMID:18443012 
  12. Pulmonary complications of haematopoietic cell transplantation in children. Paediatr Respir Rev. 2007;8(1):46-61. doi:10.1016/j.prrv.2006.04.003  PMID:17419978 
  13. American Society of Transplantation executive summary on pediatric lung transplantation. Am J Transplant. 2007;7(2):285-92. doi:10.1111/j.1600-6143.2006.01612.x  PMID:17109726 
  14. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease Pediatric Blood & Cancer. 2006;47(7):907-13. 
  15. Human bronchial epithelial cells secrete laminin 5, express hemidesmosomal proteins, and assemble hemidesmosomes. J Histochem Cytochem. 2000;48(4):535-44. PMID:10727295 
  16. Keratinocyte growth factor stimulates bronchial epithelial cell proliferation in vitro and in vivo. Am J Physiol. 1999;277(4 Pt 1):L737-42. PMID:10516214 
  17. Ozone effects on the immediate-phase response to allergen in the nasal airways of allergic asthmatic subjects. Otolaryngol Head Neck Surg. 1999;120(2):225-32. PMID:9949357 
Last updated: 10/06/2019
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130